Comparative evaluation of smear cytology & hybrid capture II for the diagnosis of cervical cancer

Indian Journal of Medical Research

Volumn 126, Issue 1, 2007, Pages 39-44

  Kumar, Kamlesh ^a   Iyer, Venkateswaran K ^a   Bhatla, Neerja ^a   Kriplani, Alka ^a   Verma, Kusum ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cervical cancer; Cytology; Hybrid capture II; Screening; Squamous intraepithelial lesion

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; GYNECOLOGICAL EXAMINATION; HIGH RISK PATIENT; HUMAN; HYBRID CAPTURE II; INDIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OUTPATIENT; PATIENT REFERRAL; PATIENT SELECTION; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS IDENTIFICATION; WART VIRUS; COMPARATIVE STUDY; CYTODIAGNOSIS; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PROSPECTIVE STUDY; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

COLPOSCOPY; CYTODIAGNOSIS; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 35548955015     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Parkin DM, Pisani P, Ferlay J. Estimates bf the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-41.
2. National Cancer Registry Programme, Two-year Report of the Population Based Cancer Registries, 1997-98, Incidence and Distribution of Cancer. New Delhi: Indian Council of Medical Research; 2002.
3. Wright TC, Kurman RJ, Ferenczy A. Precancerous lesions of the cervix. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. New York: Springer; 2002 p. 253-382.
4. Wright TC, Kurman RJ, Ferencz A. Carcinoma and other tumors of oervix. In: Kurman RJ, editor. Blaustein's pathology of the female geaital tract. New York: Springer; 2002 p. 253-382.
5. Nasiell K, Nasiell M, Vaclavinkova V. Behaviour of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol 1983; 61: 609-14.
6. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986; 67: 665-9.
7. Devasa SS, Young JL, Brinton LA, Fraumeni JF Jr. Recent trends in cervix uteri cancer. Cancer 1989; 64: 2184-90.
8. Munoz N. Human papillomaviruses and cancer; the epidemiological evidence. J Clin Virol 2000; 19: 1-5.
9. Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995; 76: 1888-901.
10. Bory JP, Cucherousset J, Lorenzato M, Gabriel R, Quereux C, Birembaut P, et al. Recurrent human papillomavirus infection detected with the Hybrid Capture II assay selects women with normal cervical smears at risk for developing high-grade cervical lesions: A longitudinal study of 3091 women. Am J Cancer 2002; 102: 519-25.
11. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. Forum group members; Bethesda 2001 workshop. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 200; 287: 2114-9.
12. Richart M. Cervical intraepithelial neoplasia: a review. In: Sommers SC, editor. Pathology annual. Appleton-Century-Crofts, East Norwalk; 1973 p. 301-28.
13. The ASC-US/LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretation of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003; 188: 1383-92.
14. Jones BA, Novis DA. Follow-up of abnormal gynaecologic cytology: A College of American Pathologists, Q-Probes study of 16132 cases from 306 laboratories. Arch Pathol Lab Med 2000; 124: 665-71.
15. Salmeron J, Lazcano-Ponce E, Lorincz A, Hernandez M, Hernandez P, Leyva A, et al. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 2003; 14: 505-12.
16. Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002; 287: 2372-81.
17. Schiffman M, Herrero-Hildesheim. A, Sherman ME, Bratti M, Wacholder S, Alfaro M, et al. HPV DNA testing in cervical cancer screening. JAMA 2000; 283: 87-93.
18. Goel A, Gandhi G, Batra S, Bhambhani S, Zutshi V, Sachdeva P. Visual inspection of the cervix with acetic acid for cervical intraepithelial lesions. Int J Gynaecol Obstet 2005; 88: 25-30.
19. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, et al. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer 1999; 80: 1306-11.
20. Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, et al. HPV testing in primary screening of older women. Br J Cancer 1999; 81: 554-8.
21. Lin CT, Tseng CJ, Lai CH, Hsueh S, Huang HJ, Law KS. High-risk HPV DNA detection by hybrid capture-II. J Reprod Med 2000; 45: 345-50.
22. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-8.
23. Franceschi S, Rajkumar R, Snijders PJF, Arslan A, Mahe C, Plummer M, et al. Papillomavirus infection in rural women in southern India. Br J Cancer 2005; 92: 601-6.
24. Joshi SN, Gopalkrishna V, Kumar BK, Dutta S, Nyaynirgune P, Thakar M, et al. Cervical squamous intra-epithelial changes and human papillomavirus infection in women infected with human immunodeficiency virus in Pune, India. J Med Virol 2005; 76: 470-5.
25. Sankaranarayanan R, Chatterji R, Shastri SS, Weslwy RS, Basu P, Mahe C, et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer 2004; 112: 341-7.
26. Sankaranarayanan R, Nene BM, Dinshaw KA, Mahe C, Jayant K, Shastri SS, et al. A cluster randomized controlled trial of visual, cytology and human papillomavirus screemng for cancer of the cervix in rural India. Int J Cancer 2005; 116: 617-23.
27. Shastri SS, Dinshaw K, Amin G, Goswami S, Patil S, Chinoy R, et al. Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ 2005, p. 186-94.
28. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahé C, et al. Cost effectiveness of cervical cancer screening in five developing countries. N Engl J Med 2005; 353: 2158-68.